Galectin-3 Inhibitor and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Galectin-3 Inhibitor Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Galectin-3 Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Galectin-3 Inhibitor Overall Market Size
2.1 Global Galectin-3 Inhibitor Market Size: 2022 VS 2029
2.2 Global Galectin-3 Inhibitor Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Galectin-3 Inhibitor Players in Global Market
3.2 Top Global Galectin-3 Inhibitor Companies Ranked by Revenue
3.3 Global Galectin-3 Inhibitor Revenue by Companies
3.4 Top 3 and Top 5 Galectin-3 Inhibitor Companies in Global Market, by Revenue in 2022
3.5 Global Companies Galectin-3 Inhibitor Product Type
3.6 Tier 1, Tier 2 and Tier 3 Galectin-3 Inhibitor Players in Global Market
3.6.1 List of Global Tier 1 Galectin-3 Inhibitor Companies
3.6.2 List of Global Tier 2 and Tier 3 Galectin-3 Inhibitor Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Galectin-3 Inhibitor Market Size Markets, 2022 & 2029
4.1.2 Natural
4.1.3 Synthetic
4.2 By Type - Global Galectin-3 Inhibitor Revenue & Forecasts
4.2.1 By Type - Global Galectin-3 Inhibitor Revenue, 2018-2023
4.2.2 By Type - Global Galectin-3 Inhibitor Revenue, 2024-2029
4.2.3 By Type - Global Galectin-3 Inhibitor Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Galectin-3 Inhibitor Market Size, 2022 & 2029
5.1.2 Diabetes
5.1.3 Heart Failure
5.1.4 Asthma
5.1.5 Rheumatoid Arthritis
5.1.6 Other
5.2 By Application - Global Galectin-3 Inhibitor Revenue & Forecasts
5.2.1 By Application - Global Galectin-3 Inhibitor Revenue, 2018-2023
5.2.2 By Application - Global Galectin-3 Inhibitor Revenue, 2024-2029
5.2.3 By Application - Global Galectin-3 Inhibitor Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Galectin-3 Inhibitor Market Size, 2022 & 2029
6.2 By Region - Global Galectin-3 Inhibitor Revenue & Forecasts
6.2.1 By Region - Global Galectin-3 Inhibitor Revenue, 2018-2023
6.2.2 By Region - Global Galectin-3 Inhibitor Revenue, 2024-2029
6.2.3 By Region - Global Galectin-3 Inhibitor Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Galectin-3 Inhibitor Revenue, 2018-2029
6.3.2 US Galectin-3 Inhibitor Market Size, 2018-2029
6.3.3 Canada Galectin-3 Inhibitor Market Size, 2018-2029
6.3.4 Mexico Galectin-3 Inhibitor Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Galectin-3 Inhibitor Revenue, 2018-2029
6.4.2 Germany Galectin-3 Inhibitor Market Size, 2018-2029
6.4.3 France Galectin-3 Inhibitor Market Size, 2018-2029
6.4.4 U.K. Galectin-3 Inhibitor Market Size, 2018-2029
6.4.5 Italy Galectin-3 Inhibitor Market Size, 2018-2029
6.4.6 Russia Galectin-3 Inhibitor Market Size, 2018-2029
6.4.7 Nordic Countries Galectin-3 Inhibitor Market Size, 2018-2029
6.4.8 Benelux Galectin-3 Inhibitor Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Galectin-3 Inhibitor Revenue, 2018-2029
6.5.2 China Galectin-3 Inhibitor Market Size, 2018-2029
6.5.3 Japan Galectin-3 Inhibitor Market Size, 2018-2029
6.5.4 South Korea Galectin-3 Inhibitor Market Size, 2018-2029
6.5.5 Southeast Asia Galectin-3 Inhibitor Market Size, 2018-2029
6.5.6 India Galectin-3 Inhibitor Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Galectin-3 Inhibitor Revenue, 2018-2029
6.6.2 Brazil Galectin-3 Inhibitor Market Size, 2018-2029
6.6.3 Argentina Galectin-3 Inhibitor Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Galectin-3 Inhibitor Revenue, 2018-2029
6.7.2 Turkey Galectin-3 Inhibitor Market Size, 2018-2029
6.7.3 Israel Galectin-3 Inhibitor Market Size, 2018-2029
6.7.4 Saudi Arabia Galectin-3 Inhibitor Market Size, 2018-2029
6.7.5 UAE Galectin-3 Inhibitor Market Size, 2018-2029
7 Galectin-3 Inhibitor Companies Profiles
7.1 GlycoMimetics (US)
7.1.1 GlycoMimetics (US) Company Summary
7.1.2 GlycoMimetics (US) Business Overview
7.1.3 GlycoMimetics (US) Galectin-3 Inhibitor Major Product Offerings
7.1.4 GlycoMimetics (US) Galectin-3 Inhibitor Revenue in Global Market (2018-2023)
7.1.5 GlycoMimetics (US) Key News & Latest Developments
7.2 Galectin Therapeutics Inc (US)
7.2.1 Galectin Therapeutics Inc (US) Company Summary
7.2.2 Galectin Therapeutics Inc (US) Business Overview
7.2.3 Galectin Therapeutics Inc (US) Galectin-3 Inhibitor Major Product Offerings
7.2.4 Galectin Therapeutics Inc (US) Galectin-3 Inhibitor Revenue in Global Market (2018-2023)
7.2.5 Galectin Therapeutics Inc (US) Key News & Latest Developments
7.3 G3 Pharmaceuticals (India)
7.3.1 G3 Pharmaceuticals (India) Company Summary
7.3.2 G3 Pharmaceuticals (India) Business Overview
7.3.3 G3 Pharmaceuticals (India) Galectin-3 Inhibitor Major Product Offerings
7.3.4 G3 Pharmaceuticals (India) Galectin-3 Inhibitor Revenue in Global Market (2018-2023)
7.3.5 G3 Pharmaceuticals (India) Key News & Latest Developments
7.4 iTeos (US)
7.4.1 iTeos (US) Company Summary
7.4.2 iTeos (US) Business Overview
7.4.3 iTeos (US) Galectin-3 Inhibitor Major Product Offerings
7.4.4 iTeos (US) Galectin-3 Inhibitor Revenue in Global Market (2018-2023)
7.4.5 iTeos (US) Key News & Latest Developments
7.5 MandalMed, Inc (US)
7.5.1 MandalMed, Inc (US) Company Summary
7.5.2 MandalMed, Inc (US) Business Overview
7.5.3 MandalMed, Inc (US) Galectin-3 Inhibitor Major Product Offerings
7.5.4 MandalMed, Inc (US) Galectin-3 Inhibitor Revenue in Global Market (2018-2023)
7.5.5 MandalMed, Inc (US) Key News & Latest Developments
7.6 Angion (US)
7.6.1 Angion (US) Company Summary
7.6.2 Angion (US) Business Overview
7.6.3 Angion (US) Galectin-3 Inhibitor Major Product Offerings
7.6.4 Angion (US) Galectin-3 Inhibitor Revenue in Global Market (2018-2023)
7.6.5 Angion (US) Key News & Latest Developments
7.7 Novartis AG (Switzerland)
7.7.1 Novartis AG (Switzerland) Company Summary
7.7.2 Novartis AG (Switzerland) Business Overview
7.7.3 Novartis AG (Switzerland) Galectin-3 Inhibitor Major Product Offerings
7.7.4 Novartis AG (Switzerland) Galectin-3 Inhibitor Revenue in Global Market (2018-2023)
7.7.5 Novartis AG (Switzerland) Key News & Latest Developments
7.8 Galecto Biotech (Denmark)
7.8.1 Galecto Biotech (Denmark) Company Summary
7.8.2 Galecto Biotech (Denmark) Business Overview
7.8.3 Galecto Biotech (Denmark) Galectin-3 Inhibitor Major Product Offerings
7.8.4 Galecto Biotech (Denmark) Galectin-3 Inhibitor Revenue in Global Market (2018-2023)
7.8.5 Galecto Biotech (Denmark) Key News & Latest Developments
7.9 Pfizer Inc. (US)
7.9.1 Pfizer Inc. (US) Company Summary
7.9.2 Pfizer Inc. (US) Business Overview
7.9.3 Pfizer Inc. (US) Galectin-3 Inhibitor Major Product Offerings
7.9.4 Pfizer Inc. (US) Galectin-3 Inhibitor Revenue in Global Market (2018-2023)
7.9.5 Pfizer Inc. (US) Key News & Latest Developments
7.10 Lilly (US)
7.10.1 Lilly (US) Company Summary
7.10.2 Lilly (US) Business Overview
7.10.3 Lilly (US) Galectin-3 Inhibitor Major Product Offerings
7.10.4 Lilly (US) Galectin-3 Inhibitor Revenue in Global Market (2018-2023)
7.10.5 Lilly (US) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Galectin-3 Inhibitor Market Opportunities & Trends in Global Market
Table 2. Galectin-3 Inhibitor Market Drivers in Global Market
Table 3. Galectin-3 Inhibitor Market Restraints in Global Market
Table 4. Key Players of Galectin-3 Inhibitor in Global Market
Table 5. Top Galectin-3 Inhibitor Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Galectin-3 Inhibitor Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Galectin-3 Inhibitor Revenue Share by Companies, 2018-2023
Table 8. Global Companies Galectin-3 Inhibitor Product Type
Table 9. List of Global Tier 1 Galectin-3 Inhibitor Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Galectin-3 Inhibitor Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Galectin-3 Inhibitor Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Galectin-3 Inhibitor Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Galectin-3 Inhibitor Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Galectin-3 Inhibitor Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Galectin-3 Inhibitor Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Galectin-3 Inhibitor Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Galectin-3 Inhibitor Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Galectin-3 Inhibitor Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Galectin-3 Inhibitor Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Galectin-3 Inhibitor Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Galectin-3 Inhibitor Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Galectin-3 Inhibitor Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Galectin-3 Inhibitor Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Galectin-3 Inhibitor Revenue, (US$, Mn), 2024-2029
Table 30. GlycoMimetics (US) Company Summary
Table 31. GlycoMimetics (US) Galectin-3 Inhibitor Product Offerings
Table 32. GlycoMimetics (US) Galectin-3 Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 33. GlycoMimetics (US) Key News & Latest Developments
Table 34. Galectin Therapeutics Inc (US) Company Summary
Table 35. Galectin Therapeutics Inc (US) Galectin-3 Inhibitor Product Offerings
Table 36. Galectin Therapeutics Inc (US) Galectin-3 Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 37. Galectin Therapeutics Inc (US) Key News & Latest Developments
Table 38. G3 Pharmaceuticals (India) Company Summary
Table 39. G3 Pharmaceuticals (India) Galectin-3 Inhibitor Product Offerings
Table 40. G3 Pharmaceuticals (India) Galectin-3 Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 41. G3 Pharmaceuticals (India) Key News & Latest Developments
Table 42. iTeos (US) Company Summary
Table 43. iTeos (US) Galectin-3 Inhibitor Product Offerings
Table 44. iTeos (US) Galectin-3 Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 45. iTeos (US) Key News & Latest Developments
Table 46. MandalMed, Inc (US) Company Summary
Table 47. MandalMed, Inc (US) Galectin-3 Inhibitor Product Offerings
Table 48. MandalMed, Inc (US) Galectin-3 Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 49. MandalMed, Inc (US) Key News & Latest Developments
Table 50. Angion (US) Company Summary
Table 51. Angion (US) Galectin-3 Inhibitor Product Offerings
Table 52. Angion (US) Galectin-3 Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 53. Angion (US) Key News & Latest Developments
Table 54. Novartis AG (Switzerland) Company Summary
Table 55. Novartis AG (Switzerland) Galectin-3 Inhibitor Product Offerings
Table 56. Novartis AG (Switzerland) Galectin-3 Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis AG (Switzerland) Key News & Latest Developments
Table 58. Galecto Biotech (Denmark) Company Summary
Table 59. Galecto Biotech (Denmark) Galectin-3 Inhibitor Product Offerings
Table 60. Galecto Biotech (Denmark) Galectin-3 Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 61. Galecto Biotech (Denmark) Key News & Latest Developments
Table 62. Pfizer Inc. (US) Company Summary
Table 63. Pfizer Inc. (US) Galectin-3 Inhibitor Product Offerings
Table 64. Pfizer Inc. (US) Galectin-3 Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Inc. (US) Key News & Latest Developments
Table 66. Lilly (US) Company Summary
Table 67. Lilly (US) Galectin-3 Inhibitor Product Offerings
Table 68. Lilly (US) Galectin-3 Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 69. Lilly (US) Key News & Latest Developments
List of Figures
Figure 1. Galectin-3 Inhibitor Segment by Type in 2022
Figure 2. Galectin-3 Inhibitor Segment by Application in 2022
Figure 3. Global Galectin-3 Inhibitor Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Galectin-3 Inhibitor Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Galectin-3 Inhibitor Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Galectin-3 Inhibitor Revenue in 2022
Figure 8. By Type - Global Galectin-3 Inhibitor Revenue Market Share, 2018-2029
Figure 9. By Application - Global Galectin-3 Inhibitor Revenue Market Share, 2018-2029
Figure 10. By Type - Global Galectin-3 Inhibitor Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Galectin-3 Inhibitor Revenue Market Share, 2018-2029
Figure 12. By Application - Global Galectin-3 Inhibitor Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Galectin-3 Inhibitor Revenue Market Share, 2018-2029
Figure 14. By Region - Global Galectin-3 Inhibitor Revenue Market Share, 2018-2029
Figure 15. By Country - North America Galectin-3 Inhibitor Revenue Market Share, 2018-2029
Figure 16. US Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Galectin-3 Inhibitor Revenue Market Share, 2018-2029
Figure 20. Germany Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 21. France Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Galectin-3 Inhibitor Revenue Market Share, 2018-2029
Figure 28. China Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 32. India Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Galectin-3 Inhibitor Revenue Market Share, 2018-2029
Figure 34. Brazil Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Galectin-3 Inhibitor Revenue Market Share, 2018-2029
Figure 37. Turkey Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Galectin-3 Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 41. GlycoMimetics (US) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Galectin Therapeutics Inc (US) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. G3 Pharmaceuticals (India) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. iTeos (US) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. MandalMed, Inc (US) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Angion (US) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis AG (Switzerland) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Galecto Biotech (Denmark) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Inc. (US) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Lilly (US) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
